14h
Frontier Medicines Appoints Veteran Drug Development Leader David R. Epstein to Board of Directors
Frontier Medicines Corporation, a clinical-stage precision medicines company unlocking the proteome to develop small molecule oncology and immunology drugs against previously undruggable ...
Health tech company Waltz Health will merge with Eversana with the goal of shaking up access to prescription drugs. The deal will bring together Waltz's proprietary drug marketplaces and ...
Following the FDA’s approval Monday of its muscular dystrophy drug, Cambridge, Mass.-based Sarepta Therapeutics plans to sell up to $255 million of stock and use the proceeds to fund clinical trials, ...
Rosa explained the company will issue financial guidance for fiscal 2026 after receiving final projections from Zimmer Biomet. "We plan on providing financial guidance for fiscal year 2026 once we ...
SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients ...
NEW YORK, March 12, 2026 /PRNewswire/ -- Medical Knowledge Group (MKG) today announced the appointment of David Margines to its Board of Directors. The move deepens the company's commitment to AI- and ...
Lilly has signed a deal with AI drug developer Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks ...
Kevin Sabet, Smart Approaches to Marijuana CEO, former White House drug policy advisor and ‘One Nation Under Influence’ author, joins 'Squawk Box' to discuss President Trump's executive order to ...
Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug NeuroSense's Groundbreaking ALS Combination Therapy PrimeC Advances Towards commercialization in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results